<DOC>
	<DOCNO>NCT00976560</DOCNO>
	<brief_summary>In randomize , double-blind , multi-centre , placebo control , exploratory , adaptive design study , antidepressant plasma cytokine lower effect GW856553 investigate adult subject diagnose MDD . Subjects receive oral dos GW856553 placebo six week . Safety , tolerability , pharmacokinetics pharmacodynamics , define biomarkers blood clinical symptom , assess . The primary endpoint change baseline associate GW856553 versus placebo Week 6 Bech ( 6-item HAMD-17 ) score . Interim analyse primary endpoint perform throughout study potentially adapt study design change randomization ratio and/ reduce total number subject randomize study . Exploratory analyse perform associate change cytokine level select clinical symptom ; PK/PD modelling also use identify sensitive clinical biological marker .</brief_summary>
	<brief_title>Clinical Study Test New Drug Treat Major Depression</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Key Adult subject primary diagnosis moderate severe MDD without psychotic feature , least 4 week one previous MDD episode Males Females agree use protocol specify contraception child bear potential BMI 18.535.0 kg/m2 Normal liver function test Key History liver disease positive hepatitis B surface antigen hepatitis C antibody last 3 month Elevated liver function test &gt; 2 ocassions last 7 month Significant medical illness , autoimmune disease infectious disease Pregnant nursing female Excessive regular alcohol consumption History substance abuse dependence past 6 month positive urine drug screen Significant suicidal homicidal risk Currently receive chronic biological pharmacologic antiinflammatory therapy euthyroid Psychoactive drug within 1 week 5 half life randomization visit Treatment resistant subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Lack interest energy</keyword>
	<keyword>Psychomotor retardation</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Major Depressive disorder</keyword>
</DOC>